The healthcare industry stands at a critical crossroads where the integration of artificial intelligence (AI) and the reinforcement of cybersecurity protocols have become the primary determinants of operational success and patient safety. MedCity News has officially initiated a specialized research project designed to capture the current sentiment, strategic direction, and technological preparedness of healthcare payers […]
The rapid proliferation of artificial intelligence within clinical environments promises to revolutionize patient outcomes and operational efficiency, yet a new report from the Peterson Health Technology Institute (PHTI) warns that the United States’ existing healthcare payment models are fundamentally ill-equipped to handle this transition. The comprehensive analysis, released following an intensive multi-sector workshop, argues that […]
The integration of artificial intelligence into the American healthcare landscape has reached a critical inflection point, where the same machine learning models revolutionizing patient diagnostics and operational efficiency are being weaponized by sophisticated cybercriminals. As hospitals across the United States accelerate their adoption of AI-driven tools to enhance clinical outcomes, they are simultaneously facing a […]
The rapid integration of artificial intelligence (AI) and machine learning (ML) into the medical device sector has created a sophisticated legal and operational paradox for developers and investors alike. At the heart of this challenge lies a fundamental product-design conflict: while the commercial and clinical value of AI often stems from its ability to continuously […]
The transition of healthcare data sharing from a conceptual vision to a functional reality has entered a pivotal phase characterized by both significant progress and systemic friction. As healthcare entities establish new digital boundaries and redefine access protocols, the industry is experiencing a period of "productive disruption." While this turbulence often manifests as administrative hurdles […]
The global women’s oncology sector is currently navigating a period of unprecedented transformation, characterized by a dual reality of robust market growth and persistent systemic inequities. According to a comprehensive new report from PwC, the market for women-specific cancers is projected to surge from its current valuation of approximately $65 billion to $75 billion to […]
The global life sciences sector is currently traversing a period of profound structural transformation as investors and companies adapt to a "higher-for-longer" interest rate environment and a recalibrated regulatory landscape. After the exuberant funding cycles of 2020 and 2021, which saw record-breaking initial public offerings (IPOs) and venture capital (VC) infusions, the industry has spent […]
The U.S. Food and Drug Administration (FDA) has granted approval to Merck’s Lipfendra, making it the first oral medication in the PCSK9 inhibitor class to reach the market. This regulatory milestone marks a significant shift in the management of cardiovascular health, providing a non-injectable alternative for millions of patients who require more intensive LDL-cholesterol lowering […]
The U.S. Food and Drug Administration (FDA) has officially granted approval for gedatolisib, a novel therapeutic developed by Minneapolis-based biotechnology firm Celcuity, marking a significant milestone in the treatment of advanced breast cancer. Marketed under the brand name Revtorpyk, the drug represents a first-in-class dual inhibitor targeting the PI3K/mTOR pathway, specifically for adult patients diagnosed […]
The digital transformation of public health over the past decade has fundamentally altered how medical records, reporting, and analytics are managed across the globe. However, despite the rapid adoption of electronic health records (EHRs), laboratory information systems, and immunization databases, a critical structural flaw persists: these systems largely operate in isolation. While the transition from […]
